LRRK2 secretion in exosomes is regulated by 14-3-3.
暂无分享,去创建一个
D. Standaert | T. Dokland | G. Siegal | A. West | P. Webber | J. Mobley | Dongquan Chen | D. Moore | M. Moehle | J. P. Daher | Kyle Fraser | Jeri Y. Williams | C. A. Stewart | T. Yacoubian | R. Cowell | Tong Ye | R. Galemmo | Elpida Tsika | K. Kojima | C. Andrew Stewart
[1] T. Beach,et al. Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies , 2013, The Biochemical journal.
[2] A. Consiglio,et al. Interplay of LRRK2 with chaperone-mediated autophagy , 2013, Nature Neuroscience.
[3] K. Marder,et al. RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk , 2013, Neuron.
[4] B. Strooper,et al. LRRK2 expression is enriched in the striosomal compartment of mouse striatum , 2012, Neurobiology of Disease.
[5] P. Verstreken,et al. LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis , 2012, Neuron.
[6] A. Hill,et al. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells , 2012, Nucleic acids research.
[7] A. Winslow,et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers , 2012, Molecular Neurodegeneration.
[8] J. Ioannidis,et al. Large-scale replication and heterogeneity in Parkinson disease genetic loci , 2012, Neurology.
[9] Xianming Deng,et al. Brain Penetrant LRRK2 Inhibitor. , 2012, ACS medicinal chemistry letters.
[10] Patrick G. A. Pedrioli,et al. The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling , 2012, PloS one.
[11] Shengdi Chen,et al. Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. , 2012, Human molecular genetics.
[12] D. Standaert,et al. LRRK2 Inhibition Attenuates Microglial Inflammatory Responses , 2012, The Journal of Neuroscience.
[13] A. West,et al. GTPase Activity and Neuronal Toxicity of Parkinson's Disease–Associated LRRK2 Is Regulated by ArfGAP1 , 2012, PLoS genetics.
[14] Yusuke Nakamura,et al. Meta‐analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis , 2011, Inflammatory bowel diseases.
[15] A. West,et al. Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities. , 2011, Journal of molecular biology.
[16] T. Dawson,et al. Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models. , 2011, Human molecular genetics.
[17] C. Wiessner,et al. Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation , 2011, PloS one.
[18] Chris Gardiner,et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission , 2011, Neurobiology of Disease.
[19] N. Gray,et al. Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2 , 2011, Nature chemical biology.
[20] W. Wurst,et al. LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool , 2011, The Journal of Neuroscience.
[21] G. Lachenal,et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity , 2011, Molecular and Cellular Neuroscience.
[22] T. Dawson,et al. Inhibitors of LRRK 2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson ’ s disease models , 2011 .
[23] A. Reith,et al. Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization , 2010, The Biochemical journal.
[24] A. Prescott,et al. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization , 2010, The Biochemical journal.
[25] D. Pisetsky,et al. The release of microparticles by RAW 264.7 macrophage cells stimulated with TLR ligands , 2010, Journal of leukocyte biology.
[26] M. Ntzouni,et al. Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival , 2010, The Journal of Neuroscience.
[27] R. J. Kelleher,et al. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice , 2010, Proceedings of the National Academy of Sciences.
[28] Ying Wang,et al. Genomewide association study of leprosy. , 2009, The New England journal of medicine.
[29] Richard Wade-Martins,et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. , 2009, Human molecular genetics.
[30] A. West,et al. Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization* , 2009, The Journal of Biological Chemistry.
[31] P. Emson,et al. Abnormal Localization of Leucine-Rich Repeat Kinase 2 to the Endosomal-Lysosomal Compartment in Lewy Body Disease , 2009, Journal of neuropathology and experimental neurology.
[32] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[33] Eugene M. Johnson,et al. MIXED LINEAGE KINASE INHIBITOR CEP- 1347 FAILS TO DELAY DISABILITY IN EARLY PARKINSON DISEASE , 2008, Neurology.
[34] N. Hattori,et al. LRRK2 regulates synaptic vesicle endocytosis. , 2008, Experimental cell research.
[35] H. Cai,et al. The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2 , 2008, The Journal of Neuroscience.
[36] Jiang Qian,et al. TiGER: A database for tissue-specific gene expression and regulation , 2008, BMC Bioinformatics.
[37] T. Dawson,et al. Dynamic and redundant regulation of LRRK2 and LRRK1 expression , 2007, BMC Neuroscience.
[38] P. Altevogt,et al. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis , 2007, Neuroscience Letters.
[39] Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease , 2007, Neurology.
[40] R. Nichols,et al. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. , 2007, The Biochemical journal.
[41] K. Lim,et al. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. , 2007, Human molecular genetics.
[42] 琢 波田野. Leucine-rich repeat kinase 2 associates with lipid rafts , 2007 .
[43] P. Emson,et al. Localization of LRRK2 to membranous and vesicular structures in mammalian brain , 2006, Annals of neurology.
[44] David W. Miller,et al. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin , 2006, Neurobiology of Disease.
[45] P. Verkade,et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Lachenal,et al. Exosomes are released by cultured cortical neurones , 2006, Molecular and Cellular Neuroscience.
[47] P. Pollak,et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.
[48] Christine Klein,et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.
[49] C. Ross,et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[50] Nicholas W Wood,et al. A common LRRK2 mutation in idiopathic Parkinson's disease , 2005, The Lancet.
[51] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[52] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[53] Rong-Fong Shen,et al. Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[54] W. Faigle,et al. Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[55] S. Masters,et al. 14-3-3 Proteins Mediate an Essential Anti-apoptotic Signal* , 2001, The Journal of Biological Chemistry.
[56] P. Ricciardi-Castagnoli,et al. Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.
[57] C. Boucheix,et al. Molecular cloning of the CD9 antigen. A new family of cell surface proteins. , 1991, The Journal of biological chemistry.